
BioBank Central Launches Online Forum to Drive Global Connectivity Among Biobanking Community

TRAIN Newsletter — September 2022

Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs

Does it Work for Patients? A Multi-Step Approach to Defining Performance and Measuring Progress Across the Biomedical Ecosystem

Medicare Drug Price Negotiation Program Comment Letter

Mapping the Patient and Caregiver Journey for Cell and Gene Therapies

Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561

Cures for Life Quarterly

Stories from the Front Lines of Advancing Therapeutic Development for Patients: The Research Acceleration and Innovation Network Enters a New Decade

Congress Passes 21st Century Cures Act, Bringing Forth New Era for Biomedical Innovation

TRAIN Newsletter — June 2023
